Examining the renin-angiotensin system one hundred years after its discovery

Nephrologie

Volumn 19, Issue 7, 1998, Pages 391-395

  Bernstein, K E ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WMB   (United States)

Author keywords

Angiotensin converting enzyme; Blood pressure; Knock out mice; Testis ACE

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; GROWTH FACTOR; ISOENZYME; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC RECOMBINATION; HYPOTENSION; KIDNEY DISEASE; KNOCKOUT MOUSE; MALE INFERTILITY; MOUSE; NONHUMAN; PHENOTYPE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEM CELL; TESTIS; TISSUE;

ANIMALS; GROWTH SUBSTANCES; HUMANS; ISOENZYMES; MALE; MICE; MICE, KNOCKOUT; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; TESTIS;

EID: 0031732589     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tigerstedt R, Bergman PG. Niere und Kreislauf. Skand Arch Physiol 1898; 7-8: 23-71.
2. Goldblatt H, Lynch J, Hanzal RF, et al. Studies on experimental hypertension. I. The production and persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59: 347-80.
3. Corvol P, Williams TA, Soubrier F. Peptidyl dipeptidase A: Angiotensin Iconverting enzyme. Meth Enzymol 1995; 248: 283-305.
4. Opie LH, Kowolik H. The discovery of captopril: From large animals to smallmolecules. Cardiovascular Res 1995; 30: 18-25.
5. Semple PF. Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors. J Hypertension 1995, (Suppl. 3): S17-21.
6. Soubrier F, Alhenc-Gelas F, Hubert C, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988; 85: 9386-90.
7. Bernstein KE, Martin BM, Edwards AS, et al. Mouse angiotensin I-converting enzyme is a protein composed of two homologous domains. J Biol Chem 1989; 264: 11945-51.
8. Rakugi H, Kim DK, Krieger JE, et al. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994; 93: 339-46.
9. Iwai N, Izumi M, Inagami T. et al. Induction of renin in medial smooth muscle cells by balloon injury. Hypertension 1997; 29: 1044-50.
10. Foy CA, Rice GI, Ossei-Gerning N, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 1997; 100: 420-5.
11. Fishel RS, Thourani V, Eisenberg SJ, et al. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. J Clin Invest 1995; 95: 377-87.
12. Powell JS, Clozel JP, Muller RK, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-8.
13. Hermans WR, Rensing BJ, Foley DP, et al. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: A quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. J Cardiovasc Pharmacol 1993; 22 (Suppl. 4): S45-57.
14. Daemen MJ, Lombardi DM, Bosman FT, et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-6.
15. Linz W, Wiemer G, Schaper J, et al. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Mol Cell Biochem 1995; 147: 89-97.
16. Chiu AT, Roscoe WA, McCall DE, et al. Angiotensin II-1 receptors mediated both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor 1991; 1: 133-40.
17. Cushman DW, Cheung HS. Studies in itro of angiotensin-converting enzyme of lung and other tissues. In Genest J, Koiw E (eds): Hypertension Nineteen Seventy-Two: Proceedings. New-York, Springer-Verlag 1972; 532-41.
18. Ehlers MR, Fox EA, Strydom DJ, et al. Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 1989; 86: 7741-5.
19. Kumar RS, Kusari J, Roy SN, et al. Structure of testicular angiotensin converting enzyme: A segmental mosaic isozyme. J Biol Chem 1989; 264: 16754-8.
20. Lattion AL, Soubrier F, Allegrinin J, et al. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett 1989; 252: 99-104.
21. Howard TE, Shai S-Y, Langford KG, et al. Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol Cell Biol 1990; 10: 4294-302.
22. Langford KG, Shai S-Y, Howard TE, et al. Transgenic mice demonstrate a testis specific promoter for angiotensin converting enzyme (ACE). J Biol Chem 1991; 266: 15559-62.
23. Howard TE, Balogh R, Overbeek P, et al. Sperm specific expression of angiotensin-converting enzyme (ACE) is mediated by a 91 base pair promoter encoding a CRE-like element. Mol Cell Biol 1992 ; 13: 18-27.
24. Zhou Y, Overbeek PA, Bernstein KE. Tissue specific expression of testis angiotensin converting enzyme is not determined by the -32 nonconsensus TATA motif. Biochem Biophys Res Comm 1996 ; 223: 48-53.
25. Zhou Y, Sun Z, Means AR, et al. CREMτ is a positive regulator of testis ACE transcription. Proc Natl Acad Sci USA 1996; 93: 12262-6.
26. Zhou Y, Delafontaine P, Martin BM, et al. Identification of two positive transcriptional elements within the 91-base pair promoter for mouse testis angiotensin converting enzyme (testis ACE). Dev Genet 1995; 16: 201-9.
27. Esther CR Jr, Semeniuk D, Marino EM, et al. Expression of testis angiotensin-converting enzyme is mediated by a cyclic AMP response element. Lab Invest 1997; 17: 483-8
28. Esther CR Jr, Howard TE, Marino EM, et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility. Lab Invest 1996; 74 :953-65.
29. Tanimoto K, Sugiyama F, Goto Y, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994; 269: 31334-7.
30. Kim HS, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92: 2735-9.
31. Niimura F, Labosky PA, Kakuchi J, et al. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1996; 96: 2947-54.
32. Esther CR Jr, Marino EM, Howard TE, et al. The critical role of tissue angiotensin converting enzyme (ACE) as revealed by gene targeting in mice. J Clin Invest 1997; 99: 2375-85.
33. Oliverio MI, Best CF, Kim HS, et al. Angiotensin II responses in AT1A receptor-deficient mice: A role for AT1B receptors in blood pressure regulation. Am J Physiol 1997; 272: F515-20.